We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 45

Sandoz Canada v Abbott Laboratories, appeal and cross-appeal of PMNOC decision, Clarithromycin extended-release, June 22, 2010
  • Gowling Lafleur Henderson LLP
  • Canada
  • August 26 2010

Sandoz served a notice of allegation ("NOA") upon Abbott and filed an Abbreviated New Drug Submission ("ANDS") with respect to clarithromycin extended-release


Eli Lilly Canada Inc. v. Apotex Inc (2010 FCA 240)
  • Gowling Lafleur Henderson LLP
  • Canada
  • October 27 2010

This was an appeal of the decision of Madame Justice Gauthier (in the Federal Court) who had found that although Lilly met its burden to prove that Apotex infringed eight Lilly process patents related to the manufacture of the antibiotic cefaclor for material imported before June 3, 1998, Lilly failed to do so for the cefaclor imported into Canada after June 3, 1998


Celgene Corporation v Canada (AG) - Supreme Court of Canada grants leave to appeal
  • Gowling Lafleur Henderson LLP
  • Canada
  • May 21 2010

The Supreme Court of Canada has granted Celgene Corporation's application for leave to appeal the decision of a majority of the Federal Court of Appeal regarding the jurisdiction of the Patented Medicine Prices Review Board


Pfizer v. Novopharm, interlocutory motion in PMNOC Regulations case
  • Gowling Lafleur Henderson LLP
  • Canada
  • May 21 2010

Novopharm served a NOA on Pfizer which it had designated confidential


Astrazeneca v. Apotex, interlocutory motion to strike affidavit in PMNOC Regulations case
  • Gowling Lafleur Henderson LLP
  • Canada
  • May 21 2010

This was an appeal to the Federal Court of Appeal (FCA) of the decision of Justice Hughes refusing to strike an affidavit from the record


Apotex Inc. v. Shire Canada Inc. (2010 FC 1001)
  • Gowling Lafleur Henderson LLP
  • Canada
  • October 27 2010

Shire appealed the Order of Prothonotary Tabib denying it permission to amend, in part, its Statement of Defence


Pfizer v Ratiopharm, appeal of decision on invalidity, Amlodipine Besylate, July 29, 2010
  • Gowling Lafleur Henderson LLP
  • Canada
  • August 26 2010

In the Federal Court, Pfizer's patent for amlodipine besylate was held invalid on numerous grounds, including obviousness


Apotex Inc. v. Pfizer Ireland Pharmaceuticals (2010 FC 968)
  • Gowling Lafleur Henderson LLP
  • Canada
  • October 27 2010

Apotex appealed an Order of Prothonotary Aalto dismissing a motion to strike parts of Pfizer’s Statement of Defence relating to res judicata, estoppel (issue and collateral), comity and abuse of process


Novopharm Limited v. Pfizer Canada inc. (2010 FCA 242)
  • Gowling Lafleur Henderson LLP
  • Canada
  • October 27 2010

Novopharm appealed the decision of the Federal Court to grant an order of prohibition to Pfizer in respect of Novopharm’s generic version of VIAGRA


Eli Lilly Canada inc. v. Apotex Inc. (2010 FC 952)
  • Gowling Lafleur Henderson LLP
  • Canada
  • October 27 2010

Apotex brought a motion to set aside an Order from 2007 granting Eli Lilly’s applications for a prohibition Order in PMNOC proceedings